The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder

Introduction: Randomized controlled trials of platinum-based neoadjuvant chemotherapy (NAC) for bladder cancer have shown that patients who achieve a pathologic response to NAC exhibit 5 y survival rates of approximately 80–90% while NAC resistant (NR) cases exhibit 5 y survival rates of approximate...

Descripción completa

Detalles Bibliográficos
Autores principales: Baras, Alexander S., Drake, Charles, Liu, Jen-Jane, Gandhi, Nilay, Kates, Max, Hoque, Mohamed O., Meeker, Alan, Hahn, Noah, Taube, Janis M., Schoenberg, Mark P., Netto, George, Bivalacqua, Trinity J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910705/
https://www.ncbi.nlm.nih.gov/pubmed/27467953
http://dx.doi.org/10.1080/2162402X.2015.1134412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910705/
https://www.ncbi.nlm.nih.gov/pubmed/27467953
http://dx.doi.org/10.1080/2162402X.2015.1134412

Ejemplares similares